Interestingly, repression of Mat1a with the induction of Mat2a, which is usually only expressed during liver development, is characteristic of NAFLD and aggressive hepatocellular carcinoma progression68–72. Here, MAT2A is linked to metabolic dysfunction-associated steatotic liver disease.